Informations générales (source: ClinicalTrials.gov)
Constitution of a Centralized Biological Resources Collection and Associated With a Clinical Database for Childhood Liver Tumors Diagnosed in France (Retrospective Collection From 1990 and Prospective) (HEPATOBIO)
Observational [Patient Registry]
Gustave Roussy, Cancer Campus, Grand Paris (Voir sur ClinicalTrials)
septembre 2015
septembre 2025
13 novembre 2024
Centralized biological collection of multicentric origin, retrospective and prospective
of biological samples (tissues and fluids) taken within the framework of the diagnostic
and therapeutic management of children and adolescents with liver tumor, and supported in
the centers of French Society for Childhood Cancers (SFCE) with associated clinical
database.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT CURIE | 09/01/2025 11:32:20 | Contacter | |||
Critères
Tous
Inclusion Criteria:
1.
- For inclusion in the clinical database:
- Children and adolescents (≤18 years at diagnosis) suffering from a primary
liver tumor diagnosed after 01/01/1990 and treated in France
- Informed consent to the computerization of data signed by the patient or by
parents or legal representatives if he is a minor.
2.
- For inclusion in the biological collection (CRB Paris Sud):
- Additional criteria:
- Availability of biological samples (tumor tissue, healthy tissue, plasma and /
or serum).
- Informed consent to the use of biological remains signed by the patient or by
parents or legal representatives if he is a minor.
3.
- For the inclusion of deceased patients:
- Obtaining consent or failing this, seeking non-opposition to the
computerization of data (for inclusion in the database) and the use of
biological remains (for inclusion in the biological collection) of the patient
or both parents or the legal guardian if he is a minor.
1.
- For inclusion in the clinical database:
- Children and adolescents (≤18 years at diagnosis) suffering from a primary
liver tumor diagnosed after 01/01/1990 and treated in France
- Informed consent to the computerization of data signed by the patient or by
parents or legal representatives if he is a minor.
2.
- For inclusion in the biological collection (CRB Paris Sud):
- Additional criteria:
- Availability of biological samples (tumor tissue, healthy tissue, plasma and /
or serum).
- Informed consent to the use of biological remains signed by the patient or by
parents or legal representatives if he is a minor.
3.
- For the inclusion of deceased patients:
- Obtaining consent or failing this, seeking non-opposition to the
computerization of data (for inclusion in the database) and the use of
biological remains (for inclusion in the biological collection) of the patient
or both parents or the legal guardian if he is a minor.
- None